GlassScriptPhysician profile
Yves A Gabriel
NPI 1457467730
$3,217.92
in general payments reported to CMS, 2019-2025
14 companies · $586 in 2025
The $586 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $301 · 2020: $245 · 2021: $82.68 · 2022: $246 · 2023: $910 · 2024: $847 · 2025: $586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,770 · Travel and Lodging: $574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,769.59 |
| Travel and Lodging | $573.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,654.74 | 2022-2025 | Gore Excluder Aaa Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Medtronic, INC. | $763.96 | 2021-2025 | Endurant Iis, Heli-Fx Endoanchor System |
| Medtronic Vascular, INC. | $194.40 | 2019-2020 | |
| Cook Medical LLC | $145.24 | 2019 | |
| Shape Memory Medical INC. | $137.50 | 2025 | Impede Embolization Plug |
| Baxter Healthcare | $130.19 | 2019-2020 | |
| Bsn Medical INC | $44.07 | 2025 | |
| Osiris Therapeutics INC. | $33.70 | 2019 | |
| Smith+Nephew, INC. | $25.78 | 2019 | |
| Ge Healthcare | $21.77 | 2021 | |
| Merck Sharp & Dohme LLC | $20.77 | 2024 | Keytruda |
| Boston Scientific Corporation | $16.76 | 2020 | |
| Angiodynamics, INC. | $14.84 | 2021 | |
| Masimo Corporation | $14.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yves Gabriel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.